1. Point of view: Should COVID-19 patients be supplemented with vitamin D?
- Author
-
Jean-Marc Sabatier, Cédric Annweiler, Zhijian Cao, Institut de neurophysiopathologie (INP), and Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
MESH: Coronavirus Infections ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Physiology ,MESH: Dietary Supplements ,law.invention ,Secosteroid ,chemistry.chemical_compound ,0302 clinical medicine ,Randomized controlled trial ,MESH: Vitamin D ,law ,Obstetrics and Gynaecology ,Medicine ,MESH: COVID-19 ,030212 general & internal medicine ,Vitamin D ,030219 obstetrics & reproductive medicine ,Incidence (epidemiology) ,Obstetrics and Gynecology ,Vitamins ,Prognosis ,Acquired immune system ,3. Good health ,Causality ,MESH: Vitamin D Deficiency ,Biomarker (medicine) ,MESH: Betacoronavirus ,Coronavirus Infections ,Adjuvant ,MESH: Pandemics ,Pneumonia, Viral ,MESH: Causality ,Article ,General Biochemistry, Genetics and Molecular Biology ,MESH: Prognosis ,Betacoronavirus ,03 medical and health sciences ,Vitamin D and neurology ,Humans ,MESH: SARS-CoV-2 ,Pandemics ,MESH: Humans ,business.industry ,SARS-CoV-2 ,COVID-19 ,Biomarker ,Vitamin D Deficiency ,Treatment ,chemistry ,MESH: Pneumonia, Viral ,Dietary Supplements ,MESH: Vitamins ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Hormone - Abstract
Highlights • Vitamin D may mitigate COVID-19 through its effects on gene expression. • Increased vitamin D concentration is associated with better prognosis in COVID-19 cases. • The benefits of vitamin D supplementation in COVID-19 patients remain to be determined. • The use of vitamin D supplements as an adjuvant treatment for COVID-19 needs to be examined urgently., Using Hill's methodology for exploring causality, we aimed to determine in early May 2020 whether evidence supports vitamin D as a biological determinant of COVID-19 outcomes. Vitamin D is a secosteroid hormone theoretically able to reduce COVID-19 risk through regulation of (i) the renin-angiotensin system, (ii) cellular innate and adaptive immunity, and (iii) physical barriers. Inverse associations were found between 25-hydroxyvitamin D concentrations and COVID-19 incidence and mortality. Randomized controlled trials testing vitamin D supplementation in the treatment of COVID-19 are in progress. Positive results in such studies would encourage the use of vitamin D supplements as an adjuvant treatment in COVID-19.
- Published
- 2020
- Full Text
- View/download PDF